AstraZeneca at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
AstraZeneca brings 5 presentations to IDWeek 2026 in Washington, and exhibits at Booth 1611, BS 11, BS 12. Its program centres on respiratory syncytial virus and human metapneumovirus, especially in adults with weakened immunity or other conditions. One study describes the structure-based design of a single vaccine against both viruses.
| Organization | IDWeek 2026 Attendance |
|---|---|
AstraZeneca Wilmington, DE | |
Global biopharmaceutical company developing and selling prescription medicines in oncology, rare diseases, respiratory, cardiovascular and other areas. | Booth Exhibiting at Booth 1611, BS 11, BS 12 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Session Fri Oct 23 12:00pm–12:55pm Poster Fri Oct 23 12:15pm–1:30pm Outcomes of Respiratory Syncytial Virus Infection Among Adults with Immunocompromising Conditions: A Systematic Literature Review Poster Sat Oct 24 12:15pm–1:30pm Incidence of Hospitalisation Due to Human Metapneumovirus (hMPV) Among Adults with Underlying Comorbidities in Spain Poster Sat Oct 24 12:15pm–1:30pm Severe Acute Respiratory Infections in Hospitalized Adults Requiring Respiratory Support in Europe: A Subgroup Analysis of the id.DRIVE Study 2024–2025 Poster Sat Oct 24 12:15pm–1:30pm Structure-based Optimization of a Bivalent Vaccine Against Respiratory Syncytial Virus and Human Metapneumovirus |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction